Vicarious Surgical Company Insiders
RBOT Stock | USD 10.80 0.52 5.06% |
Vicarious Surgical's insiders are aggressively selling. The analysis of insiders' sentiment of trading Vicarious Surgical stock suggests that vertually all insiders are panicking at this time. Vicarious Surgical employs about 123 people. The company is managed by 19 executives with a total tenure of roughly 34 years, averaging almost 1.0 years of service per executive, having 6.47 employees per reported executive.
Insider Sentiment 0
Mostly Selling
Selling | Buying |
Latest Trades
2025-06-23 | Adam David Sachs | Disposed 279 @ 7.8 | View | ||
2025-06-03 | Sammy Khalifa | Disposed 239 @ 7.25 | View | ||
2025-05-20 | Sammy Khalifa | Disposed 653 @ 7.52 | View | ||
2025-02-20 | Sammy Khalifa | Disposed 754 @ 14.53 | View | ||
2024-12-23 | William John Kelly | Disposed 19 @ 12.2 | View | ||
2024-12-03 | Adam David Sachs | Disposed 463 @ 13.5 | View | ||
2024-11-20 | William John Kelly | Disposed 109 @ 8.96 | View | ||
2024-09-20 | Sammy Khalifa | Disposed 112 @ 5.76 | View |
Monitoring Vicarious Surgical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Vicarious | Build AI portfolio with Vicarious Stock |
Vicarious Surgical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Vicarious Surgical's future performance. Based on our forecasts, it is anticipated that Vicarious will maintain a workforce of slightly above 120 employees by August 2025.Vicarious Surgical Management Team Effectiveness
The company has return on total asset (ROA) of (0.516) % which means that it has lost $0.516 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0436) %, meaning that it created substantial loss on money invested by shareholders. Vicarious Surgical's management efficiency ratios could be used to measure how well Vicarious Surgical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to -0.89 in 2025. Return On Capital Employed is likely to drop to -1.16 in 2025. At this time, Vicarious Surgical's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 25.9 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 5.7 M in 2025.Net Income Applicable To Common Shares is likely to gain to about 6.2 M in 2025, whereas Common Stock Shares Outstanding is likely to drop slightly above 5 M in 2025.
Vicarious Surgical Workforce Comparison
Vicarious Surgical is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 4,795. Vicarious Surgical holds roughly 123 in number of employees claiming about 2.57% of equities under Health Care industry.
Vicarious Surgical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Vicarious Surgical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Vicarious Surgical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Vicarious Surgical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
---|---|---|---|---|---|
2024-06-01 | 1.4286 | 10 | 7 | 548,143 | 85,094 |
2024-03-01 | 0.2222 | 2 | 9 | 1,045,998 | 100,293 |
2023-12-01 | 0.5 | 1 | 2 | 36,985 | 9,842 |
2023-09-01 | 0.1111 | 2 | 18 | 8,022,959 | 123,715 |
2023-06-01 | 1.2 | 18 | 15 | 2,454,937 | 445,638 |
2023-03-01 | 1.4615 | 19 | 13 | 838,703 | 84,308 |
2022-12-01 | 0.2692 | 7 | 26 | 129,580 | 182,715 |
2022-09-01 | 0.1739 | 8 | 46 | 1,875,297 | 8,758,067 |
2022-06-01 | 0.6957 | 16 | 23 | 2,955,468 | 2,016,377 |
2022-03-01 | 0.2105 | 4 | 19 | 272,883 | 15,059,244 |
2021-12-01 | 5.75 | 23 | 4 | 1,564,449 | 10,179 |
2021-09-01 | 7.5 | 15 | 2 | 69,520,412 | 8,535,000 |
Vicarious Surgical Notable Stakeholders
A Vicarious Surgical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Vicarious Surgical often face trade-offs trying to please all of them. Vicarious Surgical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Vicarious Surgical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
David Chu | Chief Executive Officer, Director | Profile | |
Randolph Clark | President | Profile | |
William CPA | CFO Treasurer | Profile | |
Robert Kirby | Chief Financial Officer | Profile | |
Kaitlyn Brosco | Director Relations | Profile | |
CPA CPA | CFO Treasurer | Profile | |
June Esq | Gen Officer | Profile | |
Terry Lundgren | Independent Director | Profile | |
Sammy Khalifa | CTO Cofounder | Profile | |
John Mazzola | VP Operations | Profile | |
Sarah CPA | Chief Officer | Profile | |
Michael Kives | Independent Director | Profile | |
David Ho | Independent Director | Profile | |
Donald Tang | President Director | Profile | |
Emma Plouffe | Senior People | Profile | |
Erin Checka | Head Secretary | Profile | |
Fred Langhammer | Independent Director | Profile | |
MD FACS | Cofounder Officer | Profile | |
Adam Sachs | CEO, CoFounder | Profile |
About Vicarious Surgical Management Performance
The success or failure of an entity such as Vicarious Surgical often depends on how effective the management is. Vicarious Surgical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Vicarious management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Vicarious management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.93) | (0.89) | |
Return On Capital Employed | (1.11) | (1.16) | |
Return On Assets | (0.93) | (0.89) | |
Return On Equity | (1.35) | (1.29) |
Please note, the imprecision that can be found in Vicarious Surgical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Vicarious Surgical. Check Vicarious Surgical's Beneish M Score to see the likelihood of Vicarious Surgical's management manipulating its earnings.
Vicarious Surgical Workforce Analysis
Traditionally, organizations such as Vicarious Surgical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Vicarious Surgical within its industry.Vicarious Surgical Manpower Efficiency
Return on Vicarious Surgical Manpower
Revenue Per Employee | 0.0 | |
Revenue Per Executive | 0.0 | |
Net Loss Per Employee | 514K | |
Net Loss Per Executive | 3.3M | |
Working Capital Per Employee | 358K | |
Working Capital Per Executive | 2.3M |
Additional Tools for Vicarious Stock Analysis
When running Vicarious Surgical's price analysis, check to measure Vicarious Surgical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vicarious Surgical is operating at the current time. Most of Vicarious Surgical's value examination focuses on studying past and present price action to predict the probability of Vicarious Surgical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vicarious Surgical's price. Additionally, you may evaluate how the addition of Vicarious Surgical to your portfolios can decrease your overall portfolio volatility.